Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Test-retest reliability of arterial spin labeling with common labeling strategies.

Chen Y, Wang DJ, Detre JA.

J Magn Reson Imaging. 2011 Apr;33(4):940-9. doi: 10.1002/jmri.22345.

2.

Comparing predictors of conversion and decline in mild cognitive impairment.

Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30.

3.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.

4.

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):221-9. doi: 10.1016/j.jalz.2010.03.003.

5.

Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease.

Alsop DC, Dai W, Grossman M, Detre JA.

J Alzheimers Dis. 2010;20(3):871-80. doi: 10.3233/JAD-2010-091699. Review.

6.

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ.

Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6.

7.

Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease.

Xu G, Rowley HA, Wu G, Alsop DC, Shankaranarayanan A, Dowling M, Christian BT, Oakes TR, Johnson SC.

NMR Biomed. 2010 Apr;23(3):286-93. doi: 10.1002/nbm.1462.

8.

Executive control function, brain activation and white matter hyperintensities in older adults.

Venkatraman VK, Aizenstein H, Guralnik J, Newman AB, Glynn NW, Taylor C, Studenski S, Launer L, Pahor M, Williamson J, Rosano C.

Neuroimage. 2010 Feb 15;49(4):3436-42. doi: 10.1016/j.neuroimage.2009.11.019. Epub 2009 Nov 14. Erratum in: Neuroimage. 2010 May 1;50(4):1711.

9.

Relationships between biomarkers in aging and dementia.

Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Oct 13;73(15):1193-9. doi: 10.1212/WNL.0b013e3181bc010c.

10.

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5.

11.

The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study.

Petersen ET, Mouridsen K, Golay X; all named co-authors of the QUASAR test-retest study.

Neuroimage. 2010 Jan 1;49(1):104-13. doi: 10.1016/j.neuroimage.2009.07.068. Epub 2009 Aug 4.

12.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

13.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

14.

Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging.

Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM.

Radiology. 2009 Mar;250(3):856-66. doi: 10.1148/radiol.2503080751. Epub 2009 Jan 21.

15.

Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields.

Dai W, Garcia D, de Bazelaire C, Alsop DC.

Magn Reson Med. 2008 Dec;60(6):1488-97. doi: 10.1002/mrm.21790.

16.

Hippocampal hyperperfusion in Alzheimer's disease.

Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ.

Neuroimage. 2008 Oct 1;42(4):1267-74. doi: 10.1016/j.neuroimage.2008.06.006. Epub 2008 Jun 17.

17.

Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.

Villain N, Desgranges B, Viader F, de la Sayette V, Mézenge F, Landeau B, Baron JC, Eustache F, Chételat G.

J Neurosci. 2008 Jun 11;28(24):6174-81. doi: 10.1523/JNEUROSCI.1392-08.2008.

18.

Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.

Fleisher AS, Podraza KM, Bangen KJ, Taylor C, Sherzai A, Sidhar K, Liu TT, Dale AM, Buxton RB.

Neurobiol Aging. 2009 Nov;30(11):1737-48. doi: 10.1016/j.neurobiolaging.2008.01.012. Epub 2008 Mar 5.

19.

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.

Brain. 2008 Mar;131(Pt 3):665-80. doi: 10.1093/brain/awm336. Epub 2008 Feb 7.

20.

Performance in specific language tasks correlates with regional volume changes in progressive aphasia.

Amici S, Ogar J, Brambati SM, Miller BL, Neuhaus J, Dronkers NL, Gorno-Tempini ML.

Cogn Behav Neurol. 2007 Dec;20(4):203-11.

PMID:
18091068

Supplemental Content

Support Center